Table 2 Unadjusted means of glucose and insulin markers among 268 HIV patients at baseline before initiation of antiretroviral therapy grouped by allocation to lipid-based nutrient supplements or no supplementation

Glycated hemoglobin, mmol/mol

36.1 (34.2; 37.9)

35.9 (34.6; 37.2)

 Fasting

5.6 (5.5; 5.8)

5.8 (5.7; 5.9)

 30 min^a

7.4 (7.1; 7.6)

7.9 (7.7; 8.1)

 2 h^a

6.3 (6.0; 6.6)

6.7 (6.5; 6.9)

Fasting plasma-insulin, μIU/ml^b

3.4 (2.8; 4.2)

3.1 (2.6; 3.7)

HOMA-B^b

35.0 (27.7; 44.3)

32.3 (26.8; 39.0)

HOMA-IR^b

0.8 (0.7; 1.0)

0.8 (0.6; 0.9)